Bruce A C Cree

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Silke Schmidt, Emmanuel Mignot, Stephen L Hauser, 2004, American journal of human genetics.

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Ludwig Kappos, Xavier Montalban, David H. Miller, 2016, The Lancet.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.

Adam Santaniello, Stephen L Hauser, Pouya Khankhanian, 2013, Human molecular genetics.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Gary R Cutter, Friedemann Paul, Fred D Lublin, 2019, The Lancet.